Company / Working Capital
Minerva Neurosciences, Inc. Working Capital History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$19.4M
FY2024
5-year range
$19.4M / $59.4M
FY2020-FY2024
Trend
-49.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has declined for 3 consecutive years, from $59M in FY2021 to $19M in FY2024.
Based on SEC 10-K filings.
$19M in FY2024 with a 5-year CAGR of -13.7%.
Declined from $39M to $19M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -31.1%
- 5-Year CAGR
- -13.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Minerva Neurosciences, Inc.'s working capital has declined for 3 consecutive years.
- 5-year CAGR of -13.7%, indicating a declining trend.
- In FY2024, working capital decreased 49.7% year-over-year.
- Peak working capital was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $19.4M | -49.7% |
| FY2023 | $38.7M | -0.3% |
| FY2022 | $38.8M | -34.7% |
| FY2021 | $59.4M | +144.6% |
| FY2020 | $24.3M | -40.1% |
| FY2019 | $40.5M | -53.1% |
| FY2018 | $86.4M | -29.6% |
| FY2017 | $122.7M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026